Poltreg (WAR:PTG) PEG Ratio: N/A (As of Jul. 12, 2026)


WAR:PTG Poltreg SA WAR:PTG
46 GF Score
Price zł19.15
GF Value zł14.20
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Poltreg PEG Ratio?

PE Ratio without NRI / 5-Year EBITDA Growth Rate*

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, Poltreg's PE Ratio without NRI is 0.00. Poltreg's 5-Year EBITDA growth rate is -113.90%. Therefore, Poltreg's PEG Ratio for today is N/A.

* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


The historical rank and industry rank for Poltreg's PEG Ratio or its related term are showing as below:



WAR:PTG's PEG Ratio is not ranked *
in the Biotechnology industry.
Industry Median: 1.915
* Ranked among companies with meaningful PEG Ratio only.

Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.


Poltreg  (WAR:PTG) PEG Ratio Explanation

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.


Poltreg PEG Ratio Related Terms


Poltreg PEG Ratio Historical Data

* Premium members only.

The historical data trend for Poltreg's PEG Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Poltreg PEG Ratio Chart

Poltreg Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
PEG Ratio
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Poltreg Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
PEG Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

WAR:PTG vs VRTX, REGN, ALNY: PEG Ratio Comparison

For the Biotechnology subindustry, Poltreg's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Poltreg PEG Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Poltreg's PEG Ratio distribution charts can be found below:

* The bar in red indicates where Poltreg's PEG Ratio falls into.


WAR:PTG
46GF Score
Poltreg SA WAR:PTG
PEG Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Poltreg PEG Ratio Calculation

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The ratio we use is the 5-Year EBITDA growth rate.

Poltreg's PEG Ratio for today is calculated as

PEG Ratio=PE Ratio without NRI/5-Year EBITDA Growth Rate*
=/-113.90
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.

Is Poltreg (WAR:PTG) Overvalued in 2026?

Based on GuruFocus' analysis, Poltreg stock appears to be overvalued. The current stock price of zł19.15 is trading 34.9% above its estimated GF Value™ of zł14.20. GuruFocus considers Poltreg to be Significantly Overvalued.

Key valuation signals for WAR:PTG:

  • PEG Ratio: N/A
  • GF Value™: zł14.20 vs. price of zł19.15 (34.9% above fair value)
  • GF Score™: 46/100 with 3 warning signs

No single metric tells the full story. See the WAR:PTG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Poltreg Business Description

Address ul.Botaniczna 20, Gdansk, POL, 80-298
Poltreg SA is a biotechnology company at the clinical stage developing an innovative generation of medicines using T-regulatory cells (TREGS) in the treatment of autoimmune diseases.
46GF Score

Get the complete analysis for WAR:PTG

PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł19.15
Price
zł14.20
GF Value